Preexposure Chemoprophylaxis for HIV Prevention in Men Who Have Sex with Men
Author(s) -
Robert M. Grant,
Javier R. Lama,
Peter L. Anderson,
Vanessa McMahan,
Albert Liu,
Lorena Vargas,
Pedro Goicochea,
Martín Casapía,
Juan V. Guanira,
Maria Esther Ramirez-Cardich,
Orlando Montoya-Herrera,
Telmo Fernández,
Valdiléa G. Veloso,
Susan Buchbinder,
Suwat Chariyalertsak,
Mauro Schechter,
LindaGail Bekker,
Kenneth H. Mayer,
Esper G. Kallás,
K. Rivet Amico,
Kathleen Mulligan,
Lane R. Bushman,
Robert Hance,
Carmela Ganoza,
Patricia Defechereux,
Brian S. Postle,
Furong Wang,
J. Jeff McConnell,
JiaHua Zheng,
Jeanny Lee,
James F. Rooney,
Howard S. Jaffe,
Ana I. Martínez,
David Burns,
David V. Glidden
Publication year - 2010
Publication title -
new england journal of medicine
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 19.889
H-Index - 1030
eISSN - 1533-4406
pISSN - 0028-4793
DOI - 10.1056/nejmoa1011205
Subject(s) - medicine , emtricitabine , chemoprophylaxis , placebo , pre exposure prophylaxis , adverse effect , confidence interval , incidence (geometry) , men who have sex with men , human immunodeficiency virus (hiv) , immunology , viral load , antiretroviral therapy , alternative medicine , syphilis , physics , pathology , optics
Antiretroviral chemoprophylaxis before exposure is a promising approach for the prevention of human immunodeficiency virus (HIV) acquisition.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom